The Financial Express
 
 
 
 

 

 
   INDIA-INC
Monday, October 15, 2001 
Formulating a new change prescription
  This is the age of the designer drug, says the first page of the new look Rs 911 crore Lupin Ltd’s annual report, the first after Lupin Laboratories and Lupin Chemicals were amalgamated in April 2000.
Time for a govt-industry partnership
  The incident of September 11th in the United States and the current war will only accentuate the impact of the economic slowdown that was already being felt. However, it may still be early days yet to say how things will pan out.

‘The market can take many more players’

  Anuroop ’Tony’ Singh, the CEO officer and managing director of Max New York Life Insurance Company, he is playing a pivotal role in the rollout of the company’s national operations. He is also the MD (south Asia) of New York Life International Inc. In an exclusive interview with Harjeet Ahluwalia of The Financial Express, Mr Singh talks about the insurance industry in India and Max New York Life’s India strategies.
IIMs: From competition to co-operation
  IF traditionally Indian Institute of Managements have been known for the intense competition that exists between them and its students in the placement sweepstakes, think again. Today, these same IIMs are looking at various ways in which they can share resources.

   OTHER STORIES
LG strengthens brand image through promo
AIMA to focus on expanding base of professionals
H-P to expand presence through new products
CETMA for forging closer ties with trade partners
In quest of the right market chemistry
‘I made the best use of change’
 
   
 
About Us | Advertise With Us | Privacy Policy | Feedback
© 2001: Indian Express Newspapers (Bombay) Ltd. All rights reserved throughout the world.